Fluorodeoxyglucose F18 clinical trials
Also written 18F-FDG and Fludeoxyglucose F18.
How each study uses Fluorodeoxyglucose F18 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Fluorodeoxyglucose F18 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
43 studies that test it; most in 2021 (5)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 41
Stanford University (5) · Peking Union Medical College Hospital (3) · M.D. Anderson Cancer Center (2) · University of Washington (2) · University Health Network, Toronto (2) · National Cancer Institute (NCI) (2) · Rigshospitalet, Denmark (2) · University of Pennsylvania (2)
Often tested with
Tested in the same studies.
Fluoroestradiol f-18 (2) · Florilglutamic acid f-18 (1) · Sodium fluoride f-18 (1) · 68 Ga-P16-093 (1) · Rubidium (1) · Sunitinib (1) · Cisplatin (1) · Docetaxel (1)
Related medicines
As reviewed, each with the page that says it.
- One of Radiopharmaceuticals source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 5, 1 in phase 3
Studies that test Fluorodeoxyglucose F18, phase 3 first.
- Jun 2027Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT ImagingPhase 3 · Anna Raciborska
- Feb 2027Comparison of Whole Body DWI to FDG PETNot applicable · University of California, San Francisco
- May 202718F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or TransplantPhase 1 · M.D. Anderson Cancer Center
- Sep 2027PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction EvaluationNot applicable · University Health Network, Toronto
- Nov 2027Painful Post-Operative Hip StudyPhase 2 · University of Wisconsin, Madison
Studies
Open first, then newest update. How each study uses Fluorodeoxyglucose F18 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 43
- Imaging Mitochondrial Complex-I in Alcohol Use DisorderRecruitingEarly Phase 1Rajesh NarendranNCT07825818Written as [F-18]FDG
- Painful Post-Operative Hip StudyRecruitingPhase 2University of Wisconsin, MadisonNCT07066709Written as FDG PET/MRI
- PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction EvaluationRecruitingNot applicableUniversity Health Network, TorontoNCT04901884Written as PET/MR with 18F-FDG
- PET Imaging Study of 68Ga-NB381 in Multiple MyelomaRecruitingEarly Phase 1Peking University First HospitalNCT06385652Written as 68Ga-NB381
- Glucose Consumption in MS Using [F-18]FDG-PETRecruitingPhase 4Brigham and Women's HospitalNCT07087106Written as [F-18]FDG
- Ultralow Dose PET Imaging of 18F-FDG UptakeRecruitingPhase 2Akiva MintzNCT06956391Written as 18F-FDG
- Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CTRecruitingPhase 1Peking Union Medical College HospitalNCT05121779Written as 18F-FDG
- Clinical Study of 18F-Alfatide Injection PET/CTNot yet recruitingPhase 3Yantai LNC Biotechnology Singapore PTE. LTD.NCT06416852Written as 18F-FDG Injection
- Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer PatientsEnrolling by invitationPhase 2Rigshospitalet, DenmarkNCT05396118Written as 18F-FDG
- Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine NeoplasmsEnrolling by invitationPhase 2Rigshospitalet, DenmarkNCT05709171Written as 18F-FDG
- Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial ImagingRecruitingPhase 1/2University of PennsylvaniaNCT04275453Written as FDG
- 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or TransplantActive, not recruitingPhase 1M.D. Anderson Cancer CenterNCT02379377Written as Fluorine F 18 2-deoxy-2-(18F)fluoro-D-glucose
- Comparison of Whole Body DWI to FDG PETActive, not recruitingNot applicableUniversity of California, San FranciscoNCT06630845Written as Fluorodeoxyglucose F18
- Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot StudyCompletedNot applicableUniversity Health Network, TorontoNCT02678884Written as 18-F FDG
- Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT ImagingActive, not recruitingPhase 3Anna RaciborskaNCT04943211Written as fluorodeoxyglucose (18F-FDG)
- Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted TherapyActive, not recruitingPhase 2University of WashingtonNCT04692103Written as Fludeoxyglucose F-18
- Application and Comparison of [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI in Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer PatientsCompletedNot applicableUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNCT07553741Written as 18F-FDG
- Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and WaterTerminatedPhase 1University of UtahNCT01246869Written as [18F]fluoro-2-deoxy-D-glucose (FDG)
- FDG PET-MRI for the Diagnosis of Spinal Cord LesionsCompletedNot applicableM.D. Anderson Cancer CenterNCT04219969Written as Fludeoxyglucose F-18
- Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal MetastasesCompletedPhase 2Stanford UniversityNCT00375830Written as 18F-Fludeoxyglucose (18F-FDG)
See all 43 studies that test Fluorodeoxyglucose F18 →
Given beside what is tested · 4 — Fluorodeoxyglucose F18 is usual care or a partner of the new treatment
- Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung CancerCompletedPhase 2National Cancer Institute (NCI)NCT01507428Written as Fludeoxyglucose F-18
- 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung NodulesCompletedPhase 2Andrei IagaruNCT03824535Written as Fludeoxyglucose F-18
- Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaCompletedEarly Phase 1M.D. Anderson Cancer CenterNCT02405078Written as Fludeoxyglucose F-18
- Molecular Imaging With Erlotinib and BevacizumabCompletedPhase 2University of CologneNCT01047059Written as Fluoro-D-glucose
Codes
What other systems call Fluorodeoxyglucose F18 · ClinicalTrials.gg INT008716
- MeSH (NLM) D019788Fluorodeoxyglucose F18Confirmed ClinicalTrials.gov, NLM
- UNII (FDA) 0Z5B2CJX4DFLUDEOXYGLUCOSE F-18Confirmed FDA, NLM
- RxNorm 1362737One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D019788 | Fluorodeoxyglucose F18 | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 0Z5B2CJX4D | FLUDEOXYGLUCOSE F-18 | Confirmed FDA, NLM |
| RxNorm | 1362737 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.